RegMed Daily, Closing Bell, 3/7/12, stocks recover from decline, renewing optimism, amid Greek restructuring will succeed
End of Day, Cause and Effect
EOD Commentary: Volatility has slowed down, but still lacks real volume. Stocks rise after prior-day rout, reacting to payrolls data and news that the Federal Reserve may be considering a new method to keep interest rates low. Stocks added to gains after a report that the Fed … if … it took new steps to boost the economy in the months ahead … would consider a new type of bond-buying program to subdue worries about future inflation.
Closing Bell: The NASDAQ closed UP +25.37 (+0.87%) to 2,935.69. The Dow closed UP +78.18 (+0.61%) to 12,837.33.
Who’s up … at the close:
- Aastrom (ASTM) +$0.05 <+2.78%> to $1.85;
- Athersys (ATHX) +$0.01 <+0.28%> to $1.97;
- BioMimetic (BMTI) + $0.06 <+2.94%> to $2.10;
- Cytomedix (Otc BB: CMXI) +$0.02 <+2%> to $1.02;
- Cytori (CYTX) +$0.03 <+1.15%> to $2.65;
- Dendreon (DNDN) +$0.51 <+4.92%> to $10.87;
- Geron (GERN) +$0.04 <+1.96%> to $1.83;
- NeoStem (Amex: NBS) +$0.011 <+2.03%> to $0.553;
- Osiris (OSIR) +$0.13 <+2.88%> to $4.64;
- Pluristem (PSTI) +$0.05 <+2.39%> to $2.14;
- StemCells (STEM) +$0.02 <+1.96%> to $1.04;
- Tengeon (TNGN) +$0.015 <+2.67%> to $0.57.
Related Posts
Categories: RegMed Daily Closing Bell
